In the case of Covid-19, new clinical studies could hold ... including one positing that the F.D.A.’s assessment of the Moderna shot for children in 2022 was “dishonest, and evidence that ...

said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity ...

SEOUL, April 23 (Yonhap) -- SK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the ...

Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors ... with Roth and Hemsath joining the case after Hoffmann ...

affirming that the two companies violated Moderna's patent rights during the development of their COVID-19 vaccine. The case, referenced as Az.: 4b O 62/22, has raised questions regarding the ...

In May this year, Moderna won its Covid shot patent case against Pfizer-BioNTech in Europe. Bancel will retain his role as chief executive officer, but Moderna's commercial responsibilities will ...

10 claim-construction order Moderna’s win comes ... technology used in its Covid-19 vaccine, acknowledging a federal judge’s interpretation of a disputed term in the case’s remaining patent means ...

Moderna Inc. scored a partial victory in its attempt to claim a share of billions of dollars in profits made by Pfizer Inc and BioNTech SE selling Covid-19 vaccine, after a London judge ruled that ...

MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid vaccine. The European Patent Office (EPO) has upheld the validity of one of ...

Federal judge Richard Stearns said in his ruling that waiting for the board’s decision could simplify matters in the case. Last week’s patent win for Moderna comes as COVID-19 revenues continue to ...